68Ga-CRH PET–CT is targeting CRH receptors that not only delineate corticotropinoma and provide the surgeon with valuable information for intraoperative tumor navigation but also help in differentiating a pituitary from an extra-pituitary source of ACTH-dependent CS. This evidence concerns the gene CRH and neoplasm.